Skip to main content
Formycon AG logo

Formycon AG — Investor Relations & Filings

Ticker · FYB ISIN · DE000A1EWVY8 LEI · 39120005TZ76GQOY8Z19 F Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2025-05-12 Earnings Release
Country DE Germany
Listing F FYB

About Formycon AG

https://www.formycon.com/en/

Formycon AG is an independent, globally operating biopharmaceutical company specializing in the development of high-quality biosimilars. As a pure-play biosimilar developer, the company focuses on creating follow-on products for complex biopharmaceutical medicines after their patent protection has expired. The core mission is to enhance patient access to safe, effective, and affordable biologic therapies. Formycon's development activities are concentrated in therapeutic areas with high medical need, including ophthalmology and immunology. The company manages the entire development process, from analytics and process development to clinical trials and regulatory approval submissions for its biosimilar candidates.

Recent filings

Filing Released Lang Actions
Formycon reports strong operational performance and financial results for first quarter of 2025
Earnings Release Classification · 100% confidence The document is explicitly titled "Formycon reports strong operational performance and financial results for first quarter of 2025" and contains detailed financial figures (Revenue, EBITDA) for Q1 2025 compared to Q1 2024, along with forward-looking guidance for the full year 2025. It discusses operational milestones, product launches, and includes a table summarizing key financial figures. This content structure is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results, often preceding a more comprehensive report like a 10-Q or 10-K. Since it focuses on the 'first quarter' results and provides key highlights and guidance, ER is the most appropriate classification. It is not a full, comprehensive Interim Report (IR) as it is presented as a press release summarizing results and inviting to a conference call. Q1 2025
2025-05-12 English
Q1 statement / Q1 financial report 2025
Earnings Release Classification · 100% confidence The document is explicitly titled "Press Release // May 12, 2025" and begins by reporting on "Formycon reports strong operational performance and financial results for first quarter of 2025." It details key financial figures (Revenue, EBITDA) for Q1 2025 compared to Q1 2024, confirms full-year guidance, and includes a section titled "Group revenue and EBITDA in line with expectations." This structure is characteristic of an Earnings Release (ER), which provides the initial announcement of periodical financial results and key highlights. It is not the comprehensive Annual Report (10-K) or the detailed Interim Report (IR), but rather the summary announcement. Furthermore, it includes an invitation to a conference call to discuss these results, which is common for an ER. Q1 2025
2025-05-12 English
Formycon AG: Bekanntmachung der Einberufung zur Hauptversammlung am 18.06.2025 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 99% confidence The document is titled "Bekanntmachung der Einberufung zur Hauptversammlung am 18.06.2025" (Announcement of the Invitation to the Annual General Meeting on 18.06.2025). It explicitly invites shareholders to the "ordentlichen Hauptversammlung 2025" (Ordinary Annual General Meeting 2025) and details the agenda (Tagesordnung), which includes voting on the approval of annual financial statements, discharge of management/supervisory boards, election of auditors, and remuneration matters. This content is characteristic of an official notice calling for an AGM. Therefore, the appropriate classification is AGM Information (AGM-R).
2025-05-09 German
Formycon invites to conference call on the results of the first quarter of 2025 and announces participation in international investor conferences
Report Publication Announcement Classification · 99% confidence The document is a press release dated May 7, 2025, announcing two main items: 1) The upcoming publication of the results for the first quarter of 2025 (Q1 2025) on May 12, 2025, including an invitation to a conference call to discuss these results. 2) The company's participation schedule in various international investor conferences throughout May, June, August, and September 2025. Since the document is an announcement *about* future financial results and investor events, rather than the full results themselves (which would be an IR or ER), and it is not a short notice simply stating a report is attached (which would suggest RPA), it best fits the category for announcements related to investor engagement and financial reporting schedules. The key elements are the Q1 results announcement and the investor conference schedule. This combination strongly suggests an Investor Presentation (IP) or a general announcement related to investor relations. However, since it is primarily announcing the *timing* of the Q1 results discussion (a conference call) and subsequent investor meetings, it functions as a broad update for investors. Given the options, it is not a full Earnings Release (ER) as it only announces the date of publication and call, nor is it a Call Transcript (CT). It is an announcement of future investor engagement and financial reporting events. The closest fit among the specific codes is 'Investor Presentation' (IP) if it were the presentation itself, but since it's an announcement *about* the call and future meetings, 'Regulatory Filings' (RNS) is often used for general corporate news distributed via regulatory channels, or we must check if it fits 'Report Publication Announcement' (RPA). Since it announces the *event* (conference call) where results will be discussed, and lists future investor meetings, it is a general corporate/investor relations announcement. Given the content focuses heavily on upcoming investor interactions and the date of the Q1 results call, it is most accurately classified as a general corporate announcement distributed through regulatory news services, fitting the 'RNS' fallback, or potentially 'ER' if the Q1 results announcement was the primary focus, but it explicitly states the results will be published on May 12th. Because it details participation in multiple investor conferences and the date of the earnings call announcement, it is a broad investor relations update. I will classify this as RNS as it is a general corporate news release distributed via EQS, covering multiple investor activities, rather than being the specific earnings release (ER) or a dedicated presentation (IP).
2025-05-07 English
Report Publication Announcement 2025
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of quarterly reports and quarterly/interim statements." It explicitly states that it is an announcement regarding when financial reports (specifically Quarterly/Interim statements) will be disclosed on a future date (May 12, 2025). According to Rule #2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of a report, rather than containing the report itself, should be classified as a Report Publication Announcement (RPA). The document length (1856 chars) supports this interpretation.
2025-04-14 English
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.01.2025 bis zum 31.03.2025
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 800 characters) that informs stakeholders about the availability of an interim management report for the period 01.01.2025 to 31.03.2025. It provides a link to the company's website where the actual report can be accessed. According to the 'Menu vs Meal' rule, since this is an announcement of a report's publication rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2025-04-14 German

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.